9,021 findings · Hormonal
- HormonalGood
Shift work, particularly night shifts, disrupts circadian-aligned metabolism, leading to impaired glucose tolerance, elevated triglycerides, and increased cardiovascular risk due to nocturnal eating and sleep deprivation.
If you work night shifts, prioritize lighter, lower-fat meals during the night and save heavier, nutrient-dense meals for your post-shift sleep period or morning. Avoid high-sugar snacks and large meals late at night to reduce the risk of glucose intolerance and elevated triglycerides.
Supports 2010 - HormonalGood
In men with type 2 or type 1 diabetes, lower testosterone levels (both total and calculated free testosterone) are independently associated with higher insulin resistance, and longitudinal changes in testosterone inversely correlate with changes in insulin sensitivity.
If you have diabetes and low testosterone, it is likely linked to your insulin resistance rather than just aging. Improving insulin sensitivity through weight loss and exercise may help normalize testosterone levels, though testosterone replacement therapy is not yet proven to be the primary solution.
Supports 2008 - HormonalGood
mTORC1 signaling is the central regulator of skeletal muscle mass, acting as a dual controller that promotes hypertrophy through protein synthesis and prevents atrophy by inhibiting catabolic pathways.
To maximize muscle growth, you must activate the mTOR pathway. This is achieved through resistance training (mechanical load), adequate protein intake (amino acids), and growth factors like IGF-1. Conversely, conditions that suppress mTOR (like severe caloric restriction, aging-related sarcopenia, or high cortisol) will hinder muscle maintenance. Prioritize resistance exercise and sufficient protein to keep this signaling pathway active.
Supports 2017 - HormonalGood
Prolonged sleep restriction (4 hours/night for 5 nights) increases cardiovascular disease risk by augmenting proinflammatory responses, specifically through elevated IL-17 and C-reactive protein (CRP) levels, which persist even after recovery sleep.
If you consistently restrict your sleep to around 4 hours per night for several days, your body enters a proinflammatory state characterized by high levels of IL-17 and CRP. This state persists even if you sleep normally for two days afterward. Since these markers are linked to cardiovascular disease risk, prioritizing consistent, sufficient sleep duration is critical for long-term heart health, rather than relying on weekend recovery alone.
Supports 2009 - HormonalGood
Long-term consumption of diets high in fat and/or fructose attenuates insulin and leptin production, leading to increased energy intake and contributing to weight gain and obesity.
If you eat a lot of fat and sugar, your body may produce less of the hormones (insulin and leptin) that tell your brain you are full and have enough energy. This can make you hungrier and lead to weight gain over time. It is not just about 'spiking' insulin with carbs, but how your long-term diet affects these hormonal signals.
Supports 2001 - HormonalGood
Exposure to light at night (LAN), even at dim levels (e.g., 5 lux), disrupts circadian clock gene expression in the suprachiasmatic nucleus (SCN) and peripheral tissues (e.g., liver), which alters metabolic function and contributes to obesity and metabolic disorders.
Minimize exposure to artificial light during your biological night. Even dim light (like from a phone or nightlight) can disrupt your internal clock and metabolism. Use blackout curtains, dim red lights if necessary, and avoid screens before sleep to support healthy hormone regulation and weight management.
Supports 2014 - HormonalGood
In recently postmenopausal women, 4 years of oral conjugated equine estrogens (o-CEE) combined with micronized progesterone improves depression and anxiety symptoms, whereas transdermal estradiol (t-E2) provides no mood benefit compared to placebo.
If you are a recently postmenopausal woman considering hormone therapy for mood symptoms, oral conjugated equine estrogens (CEE) combined with progesterone may help reduce depression and anxiety over 4 years. Transdermal estradiol patches did not show these mood benefits compared to placebo. Hormone therapy did not improve cognition in this study.
Qualifies 2015 - HormonalGood
Pharmacological activation of GLP-1 and amylin receptors causes sustained weight loss in humans by overriding homeostatic defenses that normally prevent long-term reduction in body fat.
Drugs that mimic GLP-1 (like semaglutide) or amylin (like pramlintide) can help you lose weight even if your body fights back by making you hungrier. This happens because the drug doses are high enough to override your body's natural defenses. Expect some nausea at first, which often gets better over time.
Supports 2008 - HormonalGood
Obesity acts as a magnifying factor in PCOS by increasing extraovarian estrogen and androgen synthesis via aromatase activity in adipose tissue, thereby worsening the hormonal imbalance.
For obese women with PCOS, even modest weight loss (5%) can significantly improve menstrual regularity and fertility outcomes by reducing the extraovarian production of hormones that worsen the condition.
Supports 2014 - HormonalGood
During midlife, women experience a cumulative 6-year increase in fat mass of 3.4 kg and a decrease in skeletal muscle mass of 0.23 kg, driven by both chronological aging and ovarian aging (menopause).
If you are a woman in your 40s or 50s, expect your body composition to shift: you will likely gain about 3.4 kg of fat and lose 0.23 kg of muscle over 6 years, largely due to hormonal changes. This is not just 'getting older' but specifically linked to ovarian aging. To counteract this, prioritize resistance training to preserve muscle mass and manage caloric intake to limit fat gain, as these changes are driven by hormonal shifts (FSH) that affect how your body stores fat and muscle.
Supports 2006 - HormonalGood
Tirzepatide, a dual GIP and GLP-1 receptor agonist, achieves superior glycemic control and weight loss compared to selective GLP-1 agonists by leveraging imbalanced receptor engagement and biased GLP-1 signaling that favors cAMP generation over beta-arrestin recruitment.
Tirzepatide is a once-weekly injection for Type 2 Diabetes that works by activating both GIP and GLP-1 receptors. It is designed to maximize blood sugar control and weight loss while minimizing the stomach side effects often seen with other GLP-1 drugs. Clinical trials show significant improvements in blood sugar and weight loss, particularly at higher doses.
Supports 2020 - HormonalGood
Obesity is fundamentally a state of chronic low-grade systemic inflammation driven by adipose tissue dysfunction, where an expansion of visceral fat leads to a shift from anti-inflammatory M2 macrophages to pro-inflammatory M1 macrophages, resulting in elevated levels of cytokines like TNF-alpha, IL-6, and resistin.
Recognize that obesity involves a biological inflammatory state, not just excess calories. This understanding shifts the focus from simple willpower to managing inflammation through medical and lifestyle interventions. While the paper highlights the problem, it notes that caloric restriction and regular exercise are effective interventions to reduce this inflammation and metabolic dysfunction.
Supports 2022 - HormonalGood
Higher waist-hip ratio (WHR) is independently and more strongly predictive of coronary heart disease (CHD) risk than body mass index (BMI) or waist circumference alone, with risk increasing continuously across the range of WHR in both men and women.
Don't rely on BMI alone to assess your heart disease risk. Measure your waist and hip circumferences. A higher waist-hip ratio indicates a significantly higher risk of coronary heart disease, even if your BMI is normal. This is a simple, inexpensive way to assess risk that captures abdominal obesity better than weight alone.
Supports 2007 - HormonalGood
Pycnogenol (100 mg/day) reduces blood glucose levels and improves endothelial function in Type 2 Diabetes patients when used as an adjunct to conventional oral antidiabetic drugs, without increasing insulin secretion.
If you have Type 2 Diabetes, adding 100 mg of Pycnogenol daily to your existing medication regimen may help lower blood sugar and improve blood vessel health over a 3-month period. It works by slowing sugar absorption rather than forcing your body to produce more insulin.
Supports 2015 - HormonalGood
Phlorizin, derived from unripe apples, reduces postprandial glucose response approximately two-fold and increases urinary glucose excretion fivefold in healthy volunteers within 2-4 hours of ingestion.
Consuming phlorizin from unripe apples can significantly blunt blood sugar spikes after a meal and increase sugar excretion in urine. This effect happens quickly, within 15-30 minutes, and lasts for a few hours.
Supports 2015 - HormonalGood
In healthy men, restricting dietary phosphorus to low-normal levels (625 mg/d) significantly decreases serum FGF-23 concentrations compared to control (1500 mg/d) or high-normal (2300 mg/d) intakes, while increasing 1,25(OH)2D levels.
For healthy men, maintaining a normal dietary phosphorus intake (around 1500 mg/day) is sufficient to regulate FGF-23 and vitamin D metabolism. Extreme restriction (625 mg/day) lowers FGF-23 and raises active Vitamin D, but this is a physiological response to restriction, not necessarily a health benefit. There is no need to restrict phosphorus in healthy individuals.
Supports 2006 - HormonalGood
In children and adolescents, higher muscular fitness is inversely associated with insulin resistance, clustered cardiometabolic risk, and inflammatory proteins, independent of cardiorespiratory fitness.
Ensure children and adolescents engage in muscle-strengthening activities. It helps regulate insulin, reduces metabolic risk, and lowers inflammation, providing benefits beyond just aerobic exercise. This is important for long-term health.
Supports 2012 - HormonalGood
Repeated exercise training produces persistent improvements in skeletal muscle insulin sensitivity through up-regulation of GLUT4, AMPK, and lipid oxidation pathways, whereas a single bout of exercise only provides a transient (approx. 48h) insulin-sensitizing effect.
To fix insulin resistance, you need to train consistently, not just occasionally. While one workout helps for a day or two, only regular exercise builds the lasting muscle adaptations (like more GLUT4 and better fat burning) that keep your blood sugar stable long-term. Focus on building a routine rather than chasing a single 'perfect' session.
Supports 2007 - HormonalGood
Exercise training restores impaired insulin-stimulated PI3-kinase (PI3K) activity in skeletal muscle, which is typically decreased in insulin-resistant subjects and type 2 diabetes patients.
Insulin resistance often involves a broken signal inside muscle cells that prevents glucose from entering. Exercise helps repair this specific signaling pathway (PI3K activity), allowing insulin to do its job of moving sugar out of the blood and into the muscle.
Supports 2007 - HormonalGood
Cocoa supplementation with high flavanol content significantly reduces systolic and diastolic blood pressure in individuals with metabolic syndrome or borderline hypertension.
To lower blood pressure, consume cocoa products that are specifically high in flavanols. Standard chocolate often lacks sufficient flavanols or contains too much sugar. Look for high-flavanol cocoa powders or dark chocolate with high cocoa content. This intervention works by improving blood vessel function via nitric oxide.
Supports 2016 - HormonalGood
Hormone Replacement Therapy (HRT) or oral contraceptives in hypoestrogenic amenorrheic athletes may prevent further bone loss but are often insufficient to stimulate bone growth or replace bone lost prior to intervention; correcting metabolic abnormalities is more effective for bone health.
If you are an amenorrheic athlete with low bone density, taking estrogen or birth control might stop your bones from getting worse, but it likely won't rebuild the bone you've already lost. The most effective way to improve bone health is to fix the underlying energy deficit and metabolic issues (eating more, training less intensely). HRT should be used cautiously and likely only after bone growth is complete in younger athletes.
Qualifies 2001 - HormonalGood
Obesity and high insulin levels are inversely correlated with Total Testosterone and SHBG levels, but weight loss increases SHBG even if insulin remains elevated.
Losing weight helps increase SHBG and Free Testosterone in obese men. However, even if insulin remains high after weight loss, SHBG can still improve, likely due to other hormonal changes.
Supports 1996 - HormonalGood
Moderate physical exercise improves endothelial function and reduces cardiovascular risk, whereas prolonged strenuous exercise may limit nitric oxide production.
Engage in moderate intensity aerobic exercise regularly to improve your heart health. This type of exercise improves endothelial function and reduces cardiovascular risk. Avoid prolonged strenuous exercise, as it may generate excessive free radicals and limit nitric oxide production, potentially negating some benefits.
Qualifies 2006 - HormonalGood
Lower visceral adipose tissue (VAT) accumulation, rather than total body fatness, is the primary physiological characteristic associated with a normal metabolic profile (high insulin sensitivity, favorable lipid profile) in obese postmenopausal women.
For obese postmenopausal women, achieving a 'normal' metabolic profile is possible even with high total body fat, provided visceral fat accumulation is kept low. This suggests that interventions targeting visceral fat reduction (via diet or exercise) may yield better metabolic outcomes than those focusing solely on total weight loss or BMI reduction.
Qualifies 2001